Tuesday, June 07, 2022 10:21:27 PM
LOL nice fantasy but completely not factual. The paragraph in the non assert agreement with MCC legally defines what Bioamber considers a "change in control". That is a fact not a provision! Should such a change of control occur; then the new entity controlling BA would need to figure out with MCC how to handle this non assert for 100,000 MT's of BioSa. If no change of control occurred then these IP licensing issues would not be "at play"...right? Well maybe you should call Gerry who represented MCC throughout the entire CCAA and ask him why he said IP licensing issues were "at play"...
BAHAHAHAHAHAHAHAHA
IE
BAHAHAHAHAHAHAHAHA
IE
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
